Position
Chief Financial Officer
Company
Inhibikase Therapeutics
AtlantaBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalDescription
Inhibikase Therapeutics has announced the appointment of David McIntyre as Chief Financial Officer, effective April 14, 2025. His extensive experience in financial strategy will be crucial as the company continues to advance its therapeutic initiatives for pulmonary arterial hypertension.
Quick answer
Inhibikase Therapeutics Appoints David McIntyre as Chief Financial Officer (April 14, 2025). Inhibikase Therapeutics is based in Atlanta, Georgia, United States.
- Who is the new Chief Financial Officer at Inhibikase Therapeutics?
- Inhibikase Therapeutics named David McIntyre Chief Financial Officer, announced April 14, 2025.
- What did Inhibikase Therapeutics announce on April 14, 2025?
- Inhibikase Therapeutics has announced the appointment of David McIntyre as Chief Financial Officer, effective April 14, 2025. His extensive experience in financial strategy will be crucial as the company continues to advance its therapeutic initiatives for pulmonary arterial hypertension.
- What does Inhibikase Therapeutics do?
- Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson's-related disorders and other...
- Where is Inhibikase Therapeutics based?
- Inhibikase Therapeutics is based in Atlanta, Georgia, United States.
- Which similar companies made leadership changes around the same time?
- Madrigal Pharmaceuticals (April 16, 2025), Werewolf Therapeutics (April 17, 2025), Qnovia (April 10, 2025) and TuHURA Biosciences (April 7, 2025) also announced leadership changes within 45 days of Inhibikase Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Madrigal Pharmaceuticals Appoints David Soergel as Chief Medical Officer (April 16, 2025)
- Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer (April 17, 2025)
- Qnovia Appoints Mario Danek as President and CEO; James Watson as COO (April 10, 2025)
- TuHURA Appoints Bertrand Le Bourdonnec as Executive Vice President (April 7, 2025)
- AEON Biopharma Appoints Rob Bancroft as Chief Executive Officer (April 22, 2025)
- Tagworks Pharmaceuticals Appoints Keith Orford as Chief Medical Officer (April 22, 2025)
Who to call at Inhibikase Therapeutics, and when
A new leader at Inhibikase Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Inhibikase Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Inhibikase Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Inhibikase Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Inhibikase Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Inhibikase Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.